Metraipolis › archive › dc_6876165f61ca

SGLT2 Inhibitors and Liver Cirrhosis: Hype or Hope? — Europe PMC PMID:41465728

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41465728
DOI
10.3390/life15121788
License (as archived)
solo-consultazione
Archived
2026-11-08T08:55:56.812Z
SHA-256 of the archived text
7b2ef1b60c4891d3e61d0f6fdf48884fd75dd740851453647b79a84fb20a6e5e
Stable URL of this page
https://metraipolis.com/documento/dc_6876165f61ca

How to cite

SGLT2 Inhibitors and Liver Cirrhosis: Hype or Hope? — Europe PMC PMID:41465728 — Europe PMC (en), https://europepmc.org/article/MED/41465728 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6876165f61ca (Metraipolis archive dc_6876165f61ca, sha256 7b2ef1b60c4891d3e61d0f6fdf48884fd75dd740851453647b79a84fb20a6e5e)
BibTeX
@misc{dc6876165f61ca,
  title = {SGLT2 Inhibitors and Liver Cirrhosis: Hype or Hope? — Europe PMC PMID:41465728},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41465728},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6876165f61ca; sha256 7b2ef1b60c4891d3e61d0f6fdf48884fd75dd740851453647b79a84fb20a6e5e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41465728. Agents can read the archived copy with the MCP tool read_document.